IsletOne Therapeutics is awarded a grant of up to a maximum of 2M SEK from Sweden's innovation agency VINNOVA.
IsletOne research published in the journal Stem Cells Translational Medicine. For more information,
IsletOne Therapeutics included in Stockholm Business Region's list of the hottest start-up companies in the Stockholm area. For more information, see http://www.investstockholm.com/Life-Science-Hotlist/